Michael Browning - Publications

Affiliations: 
UCHSC, Aurora, CO, United States 

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Penton-Voak IS, Adams S, Button KS, Fluharty M, Dalili M, Browning M, Holmes EA, Harmer CJ, Munafò MR. Emotional recognition training modifies neural response to emotional faces but does not improve mood in healthy volunteers with high levels of depressive symptoms. Psychological Medicine. 1-9. PMID 32063231 DOI: 10.1017/S0033291719004124  0.333
2020 Harmer CJ, Browning M. Can a Predictive Processing Framework Improve the Specification of Negative Bias in Depression? Biological Psychiatry. 87: 382-383. PMID 32029072 DOI: 10.1016/J.Biopsych.2019.11.019  0.303
2019 Hilland E, Landrø NI, Harmer CJ, Browning M, Maglanoc LA, Jonassen R. Attentional bias modification is associated with fMRI response toward negative stimuli in individuals with residual depression: a randomized controlled trial Journal of Psychiatry & Neuroscience : Jpn. 44: 1-11. PMID 31397551 DOI: 10.1503/Jpn.180118  0.338
2019 Jonassen R, Harmer CJ, Hilland E, Maglanoc LA, Kraft B, Browning M, Stiles TC, Haaland VØ, Berge T, Landrø NI. Effects of Attentional Bias Modification on residual symptoms in depression: a randomized controlled trial. Bmc Psychiatry. 19: 141. PMID 31068158 DOI: 10.1186/S12888-019-2105-8  0.304
2019 Ruhe HG, Mocking RJT, Figueroa CA, Seeverens PWJ, Ikani N, Tyborowska A, Browning M, Vrijsen JN, Harmer CJ, Schene AH. Emotional Biases and Recurrence in Major Depressive Disorder. Results of 2.5 Years Follow-Up of Drug-Free Cohort Vulnerable for Recurrence. Frontiers in Psychiatry. 10: 145. PMID 30984039 DOI: 10.3389/Fpsyt.2019.00145  0.329
2019 Overman M, Browning M, O'Shea J. Modulating reward learning with transcranial direct current stimulation: Applications for the treatment of depression Encephale-Revue De Psychiatrie Clinique Biologique Et Therapeutique. 45. DOI: 10.1016/J.Encep.2019.04.032  0.313
2018 Browning M, Kingslake J, Dourish CT, Goodwin GM, Harmer CJ, Dawson GR. Predicting treatment response to antidepressant medication using early changes in emotional processing. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30473402 DOI: 10.1016/J.Euroneuro.2018.11.1102  0.335
2018 Walsh AEL, Huneke NTM, Brown R, Browning M, Cowen P, Harmer CJ. A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers. Frontiers in Psychiatry. 9: 482. PMID 30386259 DOI: 10.3389/Fpsyt.2018.00482  0.324
2018 Godlewska BR, Browning M, Norbury R, Igoumenou A, Cowen PJ, Harmer CJ. Predicting treatment response in depression: the role of anterior cingulate cortex. The International Journal of Neuropsychopharmacology. PMID 30124867 DOI: 10.1093/Ijnp/Pyy069  0.305
2018 Bijsterbosch JD, Ansari TL, Smith S, Gauld O, Zika O, Boessenkool S, Browning M, Reinecke A, Bishop SJ. Stratification of MDD and GAD patients by resting state brain connectivity predicts cognitive bias. Neuroimage. Clinical. 19: 425-433. PMID 30035026 DOI: 10.1016/J.Nicl.2018.04.033  0.313
2018 Walsh AEL, Browning M, Drevets WC, Furey M, Harmer CJ. Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 29352029 DOI: 10.1098/Rstb.2017.0030  0.35
2017 Huneke NT, Walsh AE, Brown R, Browning M, Harmer CJ. No evidence for an acute placebo effect on emotional processing in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 31: 1578-1587. PMID 29182076 DOI: 10.1177/0269881117739552  0.318
2017 Kingslake J, Dias R, Dawson GR, Simon J, Goodwin GM, Harmer CJ, Morriss R, Brown S, Guo B, Dourish CT, Ruhé HG, Lever AG, Veltman DJ, van Schaik A, Deckert J, ... Browning M, et al. The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial. Trials. 18: 558. PMID 29169399 DOI: 10.1186/S13063-017-2247-2  0.321
2017 Smith J, Browning M, Conen S, Smallman R, Buchbjerg J, Larsen KG, Olsen CK, Christensen SR, Dawson GR, Deakin JF, Hawkins P, Morris R, Goodwin G, Harmer CJ. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls. Molecular Psychiatry. PMID 28533517 DOI: 10.1038/Mp.2017.104  0.335
2017 Walsh A, Browning M, Drevets W, Furey M, Harmer C. 873. Dissociable Temporal Effects of Bupropion on Behavioural Measures of Emotional and Reward Processing in Major Depressive Disorder Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.598  0.319
2017 Godlewska B, Browning M, Norbury R, Igoumenou A, Cowen P, Harmer C. 136. Neural Response to Implicit Emotions as Biomarkers of Clinical Response to SSRI Treatment in Depression Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.148  0.313
2016 Godlewska B, Browning M, Norbury R, Cowen P, Harmer CJ. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression. Translational Psychiatry. 6. PMID 27874847 DOI: 10.1038/Tp.2016.130  0.347
2015 Post A, Smart TS, Krikke-Workel J, Dawson GR, Harmer CJ, Browning M, Jackson K, Kakar R, Mohs R, Statnick M, Wafford K, McCarthy A, Barth V, Witkin JM. A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26585287 DOI: 10.1038/Npp.2015.348  0.335
2015 Cowen PJ, Browning M. What has serotonin to do with depression? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 158-60. PMID 26043325 DOI: 10.1002/Wps.20229  0.315
2015 Blackwell SE, Browning M, Mathews A, Pictet A, Welch J, Davies J, Watson P, Geddes JR, Holmes EA. Positive Imagery-Based Cognitive Bias Modification as a Web-Based Treatment Tool for Depressed Adults: A Randomized Controlled Trial. Clinical Psychological Science : a Journal of the Association For Psychological Science. 3: 91-111. PMID 25984421 DOI: 10.1177/2167702614560746  0.324
2015 Capitão LP, Murphy SE, Browning M, Cowen PJ, Harmer CJ. Acute fluoxetine modulates emotional processing in young adult volunteers. Psychological Medicine. 45: 2295-308. PMID 25864939 DOI: 10.1017/S0033291715000240  0.315
2013 Browning M, Blackwell SE, Holmes EA. The use of cognitive bias modification and imagery in the understanding and treatment of depression. Current Topics in Behavioral Neurosciences. 14: 243-60. PMID 22566082 DOI: 10.1007/7854_2012_212  0.314
2012 Browning M, Holmes EA, Charles M, Cowen PJ, Harmer CJ. Using attentional bias modification as a cognitive vaccine against depression. Biological Psychiatry. 72: 572-9. PMID 22579509 DOI: 10.1016/J.Biopsych.2012.04.014  0.319
2012 Horder J, Browning M, Di Simplicio M, Cowen PJ, Harmer CJ. Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing. Journal of Psychopharmacology (Oxford, England). 26: 125-32. PMID 21406493 DOI: 10.1177/0269881111400649  0.313
2011 Browning M, Grol M, Ly V, Goodwin GM, Holmes EA, Harmer CJ. Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2689-97. PMID 21832988 DOI: 10.1038/Npp.2011.159  0.334
2011 Hicklin TR, Wu PH, Radcliffe RA, Freund RK, Goebel-Goody SM, Correa PR, Proctor WR, Lombroso PJ, Browning MD. Alcohol inhibition of the NMDA receptor function, long-term potentiation, and fear learning requires striatal-enriched protein tyrosine phosphatase. Proceedings of the National Academy of Sciences of the United States of America. 108: 6650-5. PMID 21464302 DOI: 10.1073/Pnas.1017856108  0.475
2011 Pringle A, Browning M, Cowen PJ, Harmer CJ. A cognitive neuropsychological model of antidepressant drug action. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1586-92. PMID 20673783 DOI: 10.1016/J.Pnpbp.2010.07.022  0.328
2009 Horder J, Cowen PJ, Di Simplicio M, Browning M, Harmer CJ. Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology. 205: 85-91. PMID 19337726 DOI: 10.1007/S00213-009-1517-4  0.311
2007 Browning M, Reid C, Cowen PJ, Goodwin GM, Harmer CJ. A single dose of citalopram increases fear recognition in healthy subjects. Journal of Psychopharmacology (Oxford, England). 21: 684-90. PMID 17259206 DOI: 10.1177/0269881106074062  0.3
1989 Grebb JA, Browning MD, Valverius P, Borg S, Sedvall G, Greengard P. An analysis of postmortem brain samples from 32 alcoholic and nonalcoholic individuals for protein III, a neuronal phosphoprotein. Alcoholism, Clinical and Experimental Research. 13: 673-9. PMID 2688467 DOI: 10.1111/J.1530-0277.1989.TB00403.X  0.357
1989 Navone F, Di Gioia G, Jahn R, Browning M, Greengard P, De Camilli P. Microvesicles of the neurohypophysis are biochemically related to small synaptic vesicles of presynaptic nerve terminals. The Journal of Cell Biology. 109: 3425-33. PMID 2513331 DOI: 10.1083/Jcb.109.6.3425  0.616
1988 Browning MD, Haycock JW. Microwave radiation, in the absence of hyperthermia, has no detectable effect on synapsin I levels or phosphorylation Neurotoxicology and Teratology. 10: 461-464. PMID 3150033 DOI: 10.1016/0892-0362(88)90008-6  0.443
1988 Haycock JW, Greengard P, Browning MD. Cholinergic regulation of protein III phosphorylation in bovine adrenal chromaffin cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 3233-9. PMID 3139846  0.554
1988 Walaas SI, Browning MD, Greengard P. Synapsin Ia, synapsin Ib, protein IIIa, and protein IIIb, four related synaptic vesicle-associated phosphoproteins, share regional and cellular localization in rat brain. Journal of Neurochemistry. 51: 1214-20. PMID 3138387 DOI: 10.1111/j.1471-4159.1988.tb03089.x  0.605
1988 Haycock JW, Browning MD, Greengard P. Cholinergic regulation of protein phosphorylation in bovine adrenal chromaffin cells. Proceedings of the National Academy of Sciences of the United States of America. 85: 1677-81. PMID 2894032 DOI: 10.1523/Jneurosci.08-09-03233.1988  0.549
1987 Greengard P, Browning MD, McGuinness TL, Llinas R. Synapsin I, a phosphoprotein associated with synaptic vesicles: possible role in regulation of neurotransmitter release. Advances in Experimental Medicine and Biology. 221: 135-53. PMID 2893522 DOI: 10.1007/978-1-4684-7618-7_11  0.383
1987 Browning M, Huang C, Greengard P. Similarities between protein IIIa and protein IIIb, two prominent synaptic vesicle-associated phosphoproteins The Journal of Neuroscience. 7: 847-853. DOI: 10.1523/JNEUROSCI.07-03-00847.1987  0.371
1985 Browning MD, Huganir R, Greengard P. Protein phosphorylation and neuronal function. Journal of Neurochemistry. 45: 11-23. PMID 2582086 DOI: 10.1111/j.1471-4159.1985.tb05468.x  0.522
1983 Finn RC, Browning M, Lynch G. Trifluoperazine inhibits hippocampal long-term potentiation and the phosphorylation of a 40,000 dalton protein. Neuroscience Letters. 19: 103-8. PMID 6302592 DOI: 10.1016/0304-3940(80)90264-5  0.303
1979 Browning M, Bennett W, Lynch G. Phosphorylase kinase phosphorylates a brain protein which is influenced by repetitive synaptic activation. Nature. 278: 273-5. PMID 218113 DOI: 10.1038/278273A0  0.336
Show low-probability matches.